Michaela Scherr

Author PubWeight™ 36.86‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther 2002 4.34
2 Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood 2007 2.46
3 MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest 2013 1.80
4 Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation, left ventricular rupture, and adverse outcome in subacute myocardial infarction. Circulation 2010 1.76
5 Erythropoietin preserves the endothelial differentiation capacity of cardiac progenitor cells and reduces heart failure during anticancer therapies. Cell Stem Cell 2011 1.67
6 LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia. Nat Med 2006 1.52
7 MicroRNA and lung cancer. N Engl J Med 2005 1.37
8 Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1. Cancer Res 2007 1.34
9 Enforced expression of miR-125b affects myelopoiesis by targeting multiple signaling pathways. Blood 2011 1.16
10 Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: a key role for ubiquitin-conjugating enzymes. Eur Heart J 2010 1.14
11 Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1. Blood 2007 1.09
12 Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia. Leuk Lymphoma 2009 1.07
13 Polycomb repressor complex 2 regulates HOXA9 and HOXA10, activating ID2 in NK/T-cell lines. Mol Cancer 2010 0.96
14 Opposing roles of Akt and STAT3 in the protection of the maternal heart from peripartum stress. Cardiovasc Res 2014 0.95
15 Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in acute myeloid leukemia. Mol Cancer 2009 0.93
16 Activation of HLXB9 by juxtaposition with MYB via formation of t(6;7)(q23;q36) in an AML-M4 cell line (GDM-1). Genes Chromosomes Cancer 2005 0.92
17 Interleukin-1 assembles a proangiogenic signaling module consisting of caveolin-1, tumor necrosis factor receptor-associated factor 6, p38-mitogen-activated protein kinase (MAPK), and MAPK-activated protein kinase 2 in endothelial cells. Arterioscler Thromb Vasc Biol 2012 0.88
18 Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia. Leuk Lymphoma 2011 0.86
19 Reduction of STAT3 expression induces mitochondrial dysfunction and autophagy in cardiac HL-1 cells. Eur J Cell Biol 2012 0.86
20 Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines. Leuk Res 2009 0.86
21 Invasive drug delivery. Adv Exp Med Biol 2002 0.83
22 Activation of Paired-homeobox gene PITX1 by del(5)(q31) in T-cell acute lymphoblastic leukemia. Leuk Lymphoma 2011 0.82
23 NK-like homeodomain proteins activate NOTCH3-signaling in leukemic T-cells. BMC Cancer 2009 0.82
24 Lentivirus-mediated antagomir expression. Methods Mol Biol 2010 0.79
25 CD7 in acute myeloid leukemia: correlation with loss of wild-type CEBPA, consequence of epigenetic regulation. J Hematol Oncol 2010 0.79
26 Human leukemia and lymphoma cell lines as models and resources. Curr Med Chem 2008 0.78
27 Dendritic cells derived from HOXB4-immortalized hematopoietic bone marrow cells. Exp Biol Med (Maywood) 2011 0.77
28 Shuttle system allowing simplified cloning of expression cassettes into advanced generation lentiviral vectors. Biotechniques 2005 0.77
29 Modulation of anthracycline-induced cytotoxicity by targeting the prenylated proteome in myeloid leukemia cells. J Mol Med (Berl) 2011 0.77
30 MicroRNA-20a constrains p300-driven myocardial angiogenic transcription by direct targeting of p300. PLoS One 2013 0.77
31 RNA-mediated gene silencing in hematopoietic cells. J Biomed Biotechnol 2006 0.76
32 Comparison between molecularly defined and conventional therapeutics in a conditional BCR-ABL cell culture model. Oligonucleotides 2007 0.75
33 Insulin supplementation attenuates cancer-induced cardiomyopathy and slows tumor disease progression. JCI Insight 2017 0.75
34 Quantification of transforming capacity and cooperation of defined genetic alterations in myeloid malignancies. Exp Hematol 2010 0.75